Forte Biosciences, Inc. (NASDAQ: FBRX) related to its sale to argenx BV. Under the terms of the proposed transaction, Forte Biosciences shareholders are expected to receive $77.00 per share in cash.
Forte Biosciences, Inc. (NASDAQ: FBRX) related to its sale to argenx BV. Under the terms of the proposed transaction, Forte Biosciences shareholders are expected to receive $77.00 per share in cash.